APA (7th ed.) Citation

Stokowski, R., Wang, E., White, K., Batey, A., Jacobsson, B., Brar, H., . . . Musci, T. J. (2015). Clinical performance of non-invasive prenatal testing (NIPT) using targeted cell-free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies. Prenatal diagnosis, 35(12), 1243-1246. https://doi.org/10.1002/pd.4686

Chicago Style (17th ed.) Citation

Stokowski, Renee, et al. "Clinical Performance of Non-invasive Prenatal Testing (NIPT) Using Targeted Cell-free DNA Analysis in Maternal Plasma with Microarrays or Next Generation Sequencing (NGS) Is Consistent Across Multiple Controlled Clinical Studies." Prenatal Diagnosis 35, no. 12 (2015): 1243-1246. https://doi.org/10.1002/pd.4686.

MLA (9th ed.) Citation

Stokowski, Renee, et al. "Clinical Performance of Non-invasive Prenatal Testing (NIPT) Using Targeted Cell-free DNA Analysis in Maternal Plasma with Microarrays or Next Generation Sequencing (NGS) Is Consistent Across Multiple Controlled Clinical Studies." Prenatal Diagnosis, vol. 35, no. 12, 2015, pp. 1243-1246, https://doi.org/10.1002/pd.4686.